IRIS
GUARINO, DAVIDE MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 261
EU - Europa 159
AS - Asia 42
AF - Africa 1
SA - Sud America 1
Totale 464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 259
IT - Italia 71
IE - Irlanda 30
SE - Svezia 29
SG - Singapore 22
CN - Cina 20
UA - Ucraina 10
GB - Regno Unito 8
DK - Danimarca 4
AT - Austria 3
CA - Canada 2
DE - Germania 2
CI - Costa d'Avorio 1
FI - Finlandia 1
NL - Olanda 1
PE - Perù 1
Totale 464
Salva come PNG Salva come JPEG
Città #
Chandler 49
Dublin 30
Des Moines 26
Fairfield 19
Ashburn 18
Boardman 10
Jacksonville 10
Lawrence 10
New York 10
Princeton 10
Houston 9
San Diego 9
Turin 7
Ancona 6
Cambridge 6
Monte San Vito 5
Singapore 5
Washington 5
Dearborn 4
London 4
Seattle 4
Woodbridge 4
Bologna 3
Conversano 3
Guangzhou 3
Shanghai 3
Vienna 3
Wilmington 3
Wuhan 3
Ann Arbor 2
Arezzo 2
Bari 2
Los Angeles 2
San Benedetto del Tronto 2
San Mateo 2
Abidjan 1
Andover 1
Beijing 1
Cesano Maderno 1
Fayetteville 1
Hounslow 1
Lima 1
Montréal 1
New Bedfont 1
Pescara 1
Ponte San Pietro 1
Pontevico 1
Secaucus 1
Shenzhen 1
Southwark 1
Toronto 1
Trumbull 1
Wandsworth 1
Yiwu 1
Zibo 1
Totale 313
Salva come PNG Salva come JPEG
Nome #
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma 67
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 65
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 62
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 59
The changing scenario of hepatocellular carcinoma in Italy: an update 37
Monofocal hepatocellular carcinoma: How much does size matter? 36
Pattern of macrovascular invasion in hepatocellular carcinoma 33
Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients 30
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization 30
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 26
Identification of clinical phenotypes and related survival in patients with large hccs 24
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 6
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 5
Models of care in emergency neurology: from the Neuro Fast Track to the emergency neurologist-a position paper of the Italian Association for Emergency Neurology (ANEU) 5
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 3
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 2
Totale 490
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.097
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 1 2 2 2 1 2 0 0 4
2020/202138 2 4 4 0 7 1 6 2 4 2 4 2
2021/202259 0 2 2 0 0 1 0 1 2 1 30 20
2022/2023182 11 27 12 13 8 41 0 5 45 0 19 1
2023/2024166 13 4 7 56 15 27 2 4 2 4 18 14
2024/202522 22 0 0 0 0 0 0 0 0 0 0 0
Totale 490